Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Mira Pharmaceuticals, Inc.

NASDAQ: MIRA · Life Sciences · 5 alerts · CIK 1904286

Share price
$0.6310Close, Nov 16
Market cap
$26.5M
Shares outstanding
42.02MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Mira Pharmaceuticals, Inc. filings on SEC EDGAR ↗

8:31 AM ET 8-K
Business Update

Mira Pharmaceuticals Business Update

MIRA Pharmaceuticals has advanced its Ketamir-2 Phase 2a clinical program for chemotherapy-induced peripheral neuropathy (CIPN) toward site initiation following a protocol review by the FDA. The company has incorporated the regulator's feedback and submitted the protocol for Institutional Review Board (IRB) review, with site initiation targeted for the first quarter of 2027.

Counterparty
FDA

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.